<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To study the effects of iothalamate <z:chebi fb="199" ids="26708">sodium</z:chebi> and two dosages of iopromide in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> on infarction volume, neurologic performance, and mortality in a rat model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: Sixty-four rats underwent endovascular occlusion of the middle cerebral artery </plain></SENT>
<SENT sid="2" pm="."><plain>Four hours later, 16 animals received iothalamate <z:chebi fb="199" ids="26708">sodium</z:chebi> (588 mg <z:chebi fb="60" ids="24859">iodine</z:chebi> per kilogram); 16, iopromide as a single bolus (518 mg <z:chebi fb="60" ids="24859">iodine</z:chebi> per kilogram); and 16, iopromide as a double bolus (1,036 mg <z:chebi fb="60" ids="24859">iodine</z:chebi> per kilogram) </plain></SENT>
<SENT sid="3" pm="."><plain>Sixteen animals received equivolumetric saline (control group) </plain></SENT>
<SENT sid="4" pm="."><plain>Neurologic score and body weight were recorded every 8 hours </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-four hours after occlusion, <z:hpo ids='HP_0000001'>all</z:hpo> animals were killed; brains were stained to assess the infarction size </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Single and double doses of iopromide did not affect infarction volume or neurologic performance </plain></SENT>
<SENT sid="7" pm="."><plain>Iothalamate caused an increase in infarction volume and worsening of the neurologic score (p &lt; .05) </plain></SENT>
<SENT sid="8" pm="."><plain>Mortality rate was 25% in the iothalamate group, 12% in the control group, and 6% in the iopromide groups </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Bolus injection of the nonionic iopromide does not statistically significantly affect infarction volume or <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> symptoms </plain></SENT>
<SENT sid="10" pm="."><plain>Nonionic rather than ionic contrast agents should be preferred during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>